Besides the core business of offering pain management and physiotherapy services, SPCH has also been kept busy with administering the Covid-19 vaccinations under the national vaccination programme. It also benefited from a pick-up in foreign patients when the vaccinated travel lanes (VTL) were announced.
When Singapore Paincare Holdings (SPCH) made its debut on the Catalist Board of the Singapore Exchange (SGX) in July 2020, its intention was to become a “disruptive force” in the healthcare sector.
Two years on, CEO Dr Bernard Lee says the journey thus far has been“exciting.” Apart from raising additional funds, the company has expanded its suite of services and treaments, which has led to improved earnings. For its 1HFY2022 ended Dec 3, 2021, SPCH reported earnings of $2.27 million, up 235.9% y-o-y from the $674,887 posted in the year before. Revenue in the same period was up 70.9% y-o-y to $8.3 million, thanks to the addition of two clinics to its network.
